Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients
Pre-publication versions of this article are available by contacting email@example.com.
|20 Feb 2003||Submitted||Original manuscript|
|6 Mar 2003||Reviewed||Reviewer Report - Rolf van Heeswijk|
|18 Mar 2003||Reviewed||Reviewer Report - Leslie Huson|
|18 Apr 2003||Author responded||Author comments - Keith Pappa|
|Resubmission - Version 2|
|18 Apr 2003||Submitted||Manuscript version 2|
|29 Apr 2003||Reviewed||Reviewer Report - Leslie Huson|
|30 Apr 2003||Reviewed||Reviewer Report - Rolf van Heeswijk|
|16 May 2003||Author responded||Author comments - Keith Pappa|
|Resubmission - Version 3|
|16 May 2003||Submitted||Manuscript version 3|
|10 Jun 2003||Editorially accepted|
|10 Jun 2003||Article published||10.1186/1471-2334-3-10|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.